Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized Placebo-Controlled Trial of HSV-2 Suppression to Prevent HIV Transmission Among HIV-Discordant Couples

NCT00194519 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT00194519
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00194519 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized Placebo-Controlled Trial of HSV-2 Suppression to Prevent HIV Transmission Among HIV-Discordant Couples
Lead sponsor
University of Washington
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2004
Completion date
March 31, 2010
Enrollment
3,408 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

herpes simplex, genital, hiv infection, sexually transmitted diseases